Aleksander A. Buksh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aleksander A. Buksh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Kirill Victorovich Savostyanov
National Medical Research Center for Children’s Health, Moscow, Russia
2 shared publications - Lyudmila Mikhailovna Kuzenkova
National Medical Research Center for Children's Health, Ministry of Health of Russia
2 shared publications - Оксана Валерьевна Глоба
National Medical Research Center for Children’s Health
2 shared publications - Agata A. Zholudova
National Medical Research Center for Children’s Health
1 shared publication - Aleksander Alekseevich Pushkov
National Medical Research Center for Children’s Health, Ministry of Health of Russian Federation
1 shared publication - Anatoly Yu. Anikin
Ishlinsky Institute for Problems in Mechanics RAS, Moscow, Russia
1 shared publication
Latest Publications
- 8 November 2023
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 29 (5) , 355-366
Results of preventive medical examinations of children in Donetsk People’s Republic, Luhansk People’s Republic, and Zaporizhzhya and Kherson regions
BACKGROUND: The preventive direction of medicine has become increasingly popular in recent years. The government has paid much attention to the health of the population and preventive examinations. Among the main priorities of the state, the health of the pediatric population remains a guarantee of a healthy nation. AIM: To assess the health status of the pediatric population of the new territories of the Russian Federation and develop measures to further improve medical care at the regional level. MATERIAL AND METHODS: The study enrolled children aged 0–17 years living in the new territories of the Russian Federation, namely, the Donetsk People’s Republic, Luhansk People’s Republic, Zaporozhye oblast, and Kherson oblast. A total of 32 teams of specialists from 30 territories of the Federation have been formed to conduct in-depth preventive medical examinations of the pediatric population of these new territories. RESULTS: The study participants were predominantly children aged 0–14 years. The overall morbidity in all regions was dominated by diseases from the five classes according to ICD-10, namely, diseases of the musculoskeletal system and connective tissue; endocrine, nutritional, and metabolic diseases; of the eye and adnexa; and disorders of the nervous system, respiratory system, and psychological development. Half of the study participants were diagnosed with a disease for the first time in their lives. In the Russian Federation, the high proportion of healthy children is due to the contingent of the child population, and the third group of health with better detection of diseases due to the in-depth nature of preventive medical examinations. The distribution into groups for physical education corresponded to health groups. According to the preventive medical examinations results, more than a third of the total number of examined children was transferred to dispensary supervision. Emergent and urgent cases and mental disorders require measures under stable conditions. CONCLUSION: The results of the preventive medical examinations can be the basis for subsequent therapeutic, diagnostic, and rehabilitation work by medical organizations and preventive and health-improving activities by educational institutions.
- 8 November 2023
- Published by ECO-Vector LLC in Russian Medicine
- Vol. 29 (5) , 355-366
Results of preventive medical examinations of children in Donetsk People’s Republic, Luhansk People’s Republic, and Zaporizhzhya and Kherson regions
BACKGROUND: The preventive direction of medicine has become increasingly popular in recent years. The government has paid much attention to the health of the population and preventive examinations. Among the main priorities of the state, the health of the pediatric population remains a guarantee of a healthy nation. AIM: To assess the health status of the pediatric population of the new territories of the Russian Federation and develop measures to further improve medical care at the regional level. MATERIAL AND METHODS: The study enrolled children aged 0–17 years living in the new territories of the Russian Federation, namely, the Donetsk People’s Republic, Luhansk People’s Republic, Zaporozhye oblast, and Kherson oblast. A total of 32 teams of specialists from 30 territories of the Federation have been formed to conduct in-depth preventive medical examinations of the pediatric population of these new territories. RESULTS: The study participants were predominantly children aged 0–14 years. The overall morbidity in all regions was dominated by diseases from the five classes according to ICD-10, namely, diseases of the musculoskeletal system and connective tissue; endocrine, nutritional, and metabolic diseases; of the eye and adnexa; and disorders of the nervous system, respiratory system, and psychological development. Half of the study participants were diagnosed with a disease for the first time in their lives. In the Russian Federation, the high proportion of healthy children is due to the contingent of the child population, and the third group of health with better detection of diseases due to the in-depth nature of preventive medical examinations. The distribution into groups for physical education corresponded to health groups. According to the preventive medical examinations results, more than a third of the total number of examined children was transferred to dispensary supervision. Emergent and urgent cases and mental disorders require measures under stable conditions. CONCLUSION: The results of the preventive medical examinations can be the basis for subsequent therapeutic, diagnostic, and rehabilitation work by medical organizations and preventive and health-improving activities by educational institutions.
- Open Access
- 13 October 2023
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 4 (3) , 165-174
SCN8A epileptic encephalopathy: literature review and own observation
A genetic disease caused by pathogenetic nucleotide variants in the SCN8A gene (Sodium channel protein type 8 subunit alpha, also known as Nav1.6), encoding the α-subunit of the Na channel type 8, is included in the group of early epileptic encephalopathies. In most cases, this pathology is characterized by the development of polymorphic pharmacoresistant epileptic seizures over the first year of a child’s life, a lag in psychomotor development or regression, loss of skills. In some patients, seizures may appear during the first days of life, while in others they appear later (at the age of 2 to 7 months), against the background of a pronounced or slight developmental delay. Types of seizures may include generalized, tonic-clonic seizures, infantile spasms, absences and focal seizures. Other signs and symptoms of encephalopathy caused by mutations of the SCN8A gene may include low muscle tone (hypotension), high pain threshold, motor disorders (such as dystonia and ataxia), mild to severe mental retardation, sleep problems and autistic traits. In some people with SCN8A encephalopathy, various other pathological changes in the body have been reported, including hearing or vision impairment, scoliosis, and thermoregulation difficulties. The disease is inherited by an autosomal dominant type. To date, the disease in the OMIM system is referred to as «Developmental encephalopathy and epileptic encephalopathy type 13». Previously, the disease was called «Early infantile (infantile) epileptic encephalopathy, type 13». The serial number «13» indicates this form of early epileptic encephalopathy to be caused by a heterozygous mutation in the gene on the long arm of chromosome 12 in chromosome region 12q13.13. This report also presents a clinical description of a patient suffering from early infantile epileptic encephalopathy, type 13.
- 13 October 2023
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 4 (3) , 165-174
Open AccessSCN8A epileptic encephalopathy: literature review and own observation
A genetic disease caused by pathogenetic nucleotide variants in the SCN8A gene (Sodium channel protein type 8 subunit alpha, also known as Nav1.6), encoding the α-subunit of the Na channel type 8, is included in the group of early epileptic encephalopathies. In most cases, this pathology is characterized by the development of polymorphic pharmacoresistant epileptic seizures over the first year of a child’s life, a lag in psychomotor development or regression, loss of skills. In some patients, seizures may appear during the first days of life, while in others they appear later (at the age of 2 to 7 months), against the background of a pronounced or slight developmental delay. Types of seizures may include generalized, tonic-clonic seizures, infantile spasms, absences and focal seizures. Other signs and symptoms of encephalopathy caused by mutations of the SCN8A gene may include low muscle tone (hypotension), high pain threshold, motor disorders (such as dystonia and ataxia), mild to severe mental retardation, sleep problems and autistic traits. In some people with SCN8A encephalopathy, various other pathological changes in the body have been reported, including hearing or vision impairment, scoliosis, and thermoregulation difficulties. The disease is inherited by an autosomal dominant type. To date, the disease in the OMIM system is referred to as «Developmental encephalopathy and epileptic encephalopathy type 13». Previously, the disease was called «Early infantile (infantile) epileptic encephalopathy, type 13». The serial number «13» indicates this form of early epileptic encephalopathy to be caused by a heterozygous mutation in the gene on the long arm of chromosome 12 in chromosome region 12q13.13. This report also presents a clinical description of a patient suffering from early infantile epileptic encephalopathy, type 13.
- 30 June 2022
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 3 (2) , 82-95
Glutaric acidemia type 1 (clinical cases)
Glutaric aciduria type 1 (glutaryl-CoA dehydrogenase deficiency, glutaric acidemia type 1) (OMIM 231670) is an autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl-CoA dehydrogenase (GCDH). Glutaryl-CoA dehydrogenase (GCDH) plays an important role in the degradation metabolism of L-lysine, L-hydroxylysine and L-tryptophan. The insufficiency or absence of the enzyme leads to the accumulation of by-products of degradation of such amino acids as glutaric acid, 3-hydroxyglutaric acid, glutarylcarnitine (C5DC-acylcarnitine) and glutaconic acid. The accumulation of glutaric acid and 3-OH-glutaric acid causes neurotoxicity. Glutaric aciduria type 1 can manifest itself in early childhood with encephalitis-like crises: from three months to three years as GA-1 with infantile onset or from the age of six years as the late onset of GA-1. It is characterized by progressive neurological motor disorders, with the appearance of various types of hyperkinesis in combination with spasticity, a high incidence of disability and mortality. In about 25% of cases, the disease has a subacute course and manifests over the first year of life with a delay in psychomotor development, the gradual development of hyperkinetic syndrome, and spasticity. Awareness of doctors and alertness regarding diseases from the group of hereditary metabolic diseases will help to carry out therapy in a timely manner both in the acute period and in the appointment of long-term therapy to prevent disability of patients.
- 30 June 2022
- Published by National Medical Research Center for Childrens Health in L.O. Badalyan Neurological Journal
- Vol. 3 (2) , 82-95
Glutaric acidemia type 1 (clinical cases)
Glutaric aciduria type 1 (glutaryl-CoA dehydrogenase deficiency, glutaric acidemia type 1) (OMIM 231670) is an autosomal recessive disease caused by mutations in the gene encoding the enzyme glutaryl-CoA dehydrogenase (GCDH). Glutaryl-CoA dehydrogenase (GCDH) plays an important role in the degradation metabolism of L-lysine, L-hydroxylysine and L-tryptophan. The insufficiency or absence of the enzyme leads to the accumulation of by-products of degradation of such amino acids as glutaric acid, 3-hydroxyglutaric acid, glutarylcarnitine (C5DC-acylcarnitine) and glutaconic acid. The accumulation of glutaric acid and 3-OH-glutaric acid causes neurotoxicity. Glutaric aciduria type 1 can manifest itself in early childhood with encephalitis-like crises: from three months to three years as GA-1 with infantile onset or from the age of six years as the late onset of GA-1. It is characterized by progressive neurological motor disorders, with the appearance of various types of hyperkinesis in combination with spasticity, a high incidence of disability and mortality. In about 25% of cases, the disease has a subacute course and manifests over the first year of life with a delay in psychomotor development, the gradual development of hyperkinetic syndrome, and spasticity. Awareness of doctors and alertness regarding diseases from the group of hereditary metabolic diseases will help to carry out therapy in a timely manner both in the acute period and in the appointment of long-term therapy to prevent disability of patients.